Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 2
2009 1
2010 4
2011 3
2012 2
2013 1
2014 1
2015 1
2016 3
2017 1
2018 1
2019 2
2020 7
2021 9
2022 9
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19.
Farge D, Frere C, Connors JM, Khorana AA, Kakkar A, Ay C, Muñoz A, Brenner B, Prata PH, Brilhante D, Antic D, Casais P, Guillermo Esposito MC, Ikezoe T, Abutalib SA, Meillon-García LA, Bounameaux H, Pabinger I, Douketis J; International Initiative on Thrombosis and Cancer (ITAC) advisory panel. Farge D, et al. Lancet Oncol. 2022 Jul;23(7):e334-e347. doi: 10.1016/S1470-2045(22)00160-7. Lancet Oncol. 2022. PMID: 35772465 Free PMC article. Review.
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.
Farge D, Frere C, Connors JM, Ay C, Khorana AA, Munoz A, Brenner B, Kakkar A, Rafii H, Solymoss S, Brilhante D, Monreal M, Bounameaux H, Pabinger I, Douketis J; International Initiative on Thrombosis and Cancer (ITAC) advisory panel. Farge D, et al. Lancet Oncol. 2019 Oct;20(10):e566-e581. doi: 10.1016/S1470-2045(19)30336-5. Epub 2019 Sep 3. Lancet Oncol. 2019. PMID: 31492632
Long-term effects on subclinical cardiovascular disease of switching from boosted protease inhibitors to dolutegravir.
González-Cordón A, Assoumou L, Moyle G, Waters L, Johnson M, Domingo P, Fox J, Stellbrink HJ, Guaraldi G, Masiá M, Gompels M, De Wit S, Florence E, Esser S, Raffi F, Behrens G, Pozniak A, Gatell JM, Martínez E; NEAT 022 Study Group. González-Cordón A, et al. J Antimicrob Chemother. 2023 Sep 5;78(9):2361-2365. doi: 10.1093/jac/dkad247. J Antimicrob Chemother. 2023. PMID: 37539492
Case-Control Study on Exercise-Induced Vasculitis in Hikers.
Quéneau A, Pistorius MA, Connault J, Raimbeau A, Gautier G, Bergère G, Artifoni M, Durant C, Bénichou A, Hersant J, Espitia O. Quéneau A, et al. Among authors: connault j. Angiology. 2022 Aug;73(7):643-648. doi: 10.1177/00033197211065792. Epub 2022 Jan 6. Angiology. 2022. PMID: 34989632
Limited Weight Impact After Switching From Boosted Protease Inhibitors to Dolutegravir in Persons With Human Immunodeficiency Virus With High Cardiovascular Risk: A Post Hoc Analysis of the 96-Week NEAT-022 Randomized Trial.
Waters L, Assoumou L, González-Cordón A, Rusconi S, Domingo P, Gompels M, de Wit S, Raffi F, Stephan C, Masiá M, Rockstroh J, Katlama C, Behrens GMN, Moyle G, Johnson M, Fox J, Stellbrink HJ, Guaraldi G, Florence E, Esser S, Gatell JM, Pozniak A, Martínez E; NEAT 022 Study Group. Waters L, et al. Clin Infect Dis. 2023 Mar 4;76(5):861-870. doi: 10.1093/cid/ciac827. Clin Infect Dis. 2023. PMID: 36259527 Clinical Trial.
Predictive factors of venous recanalization in upper-extremity vein thrombosis.
Ploton G, Brebion N, Guyomarch B, Pistorius MA, Connault J, Hersant J, Raimbeau A, Bergère G, Artifoni M, Durant C, Gautier G, Dumont R, Kubina JM, Toquet C, Espitia O. Ploton G, et al. Among authors: connault j. PLoS One. 2021 May 13;16(5):e0251269. doi: 10.1371/journal.pone.0251269. eCollection 2021. PLoS One. 2021. PMID: 33983979 Free PMC article.
Comparison of idiopathic (isolated) aortitis and giant cell arteritis-related aortitis. A French retrospective multicenter study of 117 patients.
Espitia O, Samson M, Le Gallou T, Connault J, Landron C, Lavigne C, Belizna C, Magnant J, de Moreuil C, Roblot P, Maillot F, Diot E, Jégo P, Durant C, Masseau A, Brisseau JM, Pottier P, Espitia-Thibault A, Santos AD, Perrin F, Artifoni M, Néel A, Graveleau J, Moreau P, Maisonneuve H, Fau G, Serfaty JM, Hamidou M, Agard C. Espitia O, et al. Among authors: connault j. Autoimmun Rev. 2016 Jun;15(6):571-6. doi: 10.1016/j.autrev.2016.02.016. Epub 2016 Feb 20. Autoimmun Rev. 2016. PMID: 26903476 Free article. Review.
Prevalence of post-thrombotic syndrome in a cohort of upper extremity vein thrombosis.
Hervé H, Toquet C, Ploton G, Connault J, Gautier G, Raimbeau A, Bergère G, Hersant J, Durant C, Artifoni M, Brebion N, Kubina JM, Pistorius MA, Espitia O. Hervé H, et al. Among authors: connault j. J Vasc Surg Venous Lymphat Disord. 2022 Jan;10(1):111-117.e3. doi: 10.1016/j.jvsv.2021.04.006. Epub 2021 Apr 21. J Vasc Surg Venous Lymphat Disord. 2022. PMID: 33894342
Digital necrosis revealing giant cell arteritis.
Artifoni M, Connault J, Goueffic Y, Durant C. Artifoni M, et al. Among authors: connault j. Arthritis Rheumatol. 2014 Aug;66(8):2090. doi: 10.1002/art.38640. Arthritis Rheumatol. 2014. PMID: 24664594 No abstract available.
46 results